Trials / Completed
CompletedNCT02602483
Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).
Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Spherium Biomed · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objetive of this study is to explore the efficacy and safety of a triple combination of ibuprofen, magnesium and ascorbic acid for acute pain treatment in TMJD patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen | |
| DRUG | Magnesium | |
| DRUG | Ascorbic Acid | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-11-11
- Last updated
- 2017-01-19
Locations
4 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02602483. Inclusion in this directory is not an endorsement.